Logos Global Management LP Lian Bio Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.14 - $2.11 $31,815 - $58,885	-27,908 Reduced 9.06%	280,000 $459,000
Q3 2022 Nov 14, 2022	SELL	$1.87 - $3.0 $161,900 - $259,734	-86,578 Reduced 21.95%	307,908 $616,000
Q2 2022 Aug 15, 2022	SELL	$2.15 - $6.01 $39,454 - $110,289	-18,351 Reduced 4.45%	394,486 $852,000
Q4 2021 Feb 14, 2022	BUY	$6.14 - $16.2 $2.53 Million - $6.69 Million	412,837 New	412,837 $2.54 Million

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.